CUAMC
BCRX icon

China Universal Asset Management Company’s BioCryst Pharmaceuticals BCRX Stock Holding History

China Universal Asset Management Company’s Portfolio BCRX Stock Details BCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$405K Sell
40,450
-4,057
-9% -$36.7K 0.02% 281
2026
Q1 		$424K Buy
44,507
+10,199
+30% +$79.2K 0.03% 271
2025
Q4 		$268K Sell
34,308
-2,488
-7% -$18K 0.02% 317
2025
Q3 		$279K Sell
36,796
-5,231
-12% -$43.6K 0.02% 302
2025
Q2 		$377K Buy
42,027
+113
+0.3% +$1.05K 0.04% 264
2025
Q1 		$314K Sell
41,914
-2,006
-5% -$16.2K 0.03% 283
2024
Q4 		$330K Buy
43,920
+4,129
+10% +$31.3K 0.03% 289
2024
Q3 		$302K Buy
39,791
+15,544
+64% +$118K 0.03% 269
2024
Q2 		$150K Sell
24,247
-15,392
-39% -$84.9K 0.02% 270
2024
Q1 		$201K Buy
39,639
+15,947
+67% +$89.7K 0.03% 287
2023
Q4 		$142K Buy
23,692
+18,827
+387% +$109K 0.03% 246
2023
Q3 		$34.4K Buy
4,865
+2,388
+96% +$17.2K 0.01% 254
2023
Q2 		$17.4K Sell
2,477
-77
-3% -$618 0.01% 281
2023
Q1 		$21.3K Buy
2,554
+661
+35% +$6.36K 0.01% 212
2022
Q4 		$21.7K Buy
1,893
+152
+9% +$1.9K 0.01% 168
2022
Q3 		$22K Buy
+1,741
New +$22.4K 0.01% 151

Other funds holding BCRX

OAM
OP Asset Management Helsinki $9.38B AUM 42.35% 1-Year Est. Return
NFT
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
DA
Doliver Advisors Houston, Texas $442M AUM 34.09% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
QFW
QTR Family Wealth Lake Mary, Florida $287M AUM 40.55% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CV
Counterweight Ventures Wilmington, North Carolina $201M AUM 35.56% 1-Year Est. Return

China Universal Asset Management Company's BCRX Position: Q2 2026 in Review

China Universal Asset Management Company reduced its BioCryst Pharmaceuticals (BCRX) stake by 9.1% in Q2 2026, selling an estimated $36.7K and leaving 40,450 shares worth $405K. The position accounts for 0.02% of the portfolio, ranked #281.

China Universal Asset Management Company first reported a position in BCRX in Q3 2022 and has held it in 16 quarters since. The position peaked at $424K in Q1 2026. 52 funds tracked by Wall St. Rank hold BCRX as of Q2 2026.

  • China Universal Asset Management Company held 40,450 shares of BioCryst Pharmaceuticals worth $405K as of Q2 2026.
  • China Universal Asset Management Company sold 4,057 BioCryst Pharmaceuticals shares in Q2 2026, an estimated $36.7K.
  • BioCryst Pharmaceuticals made up 0.02% of China Universal Asset Management Company's portfolio in Q2 2026, its #281 holding.
  • China Universal Asset Management Company first reported a position in BioCryst Pharmaceuticals in Q3 2022 and has held it in 16 quarters since.
  • China Universal Asset Management Company's BioCryst Pharmaceuticals position peaked at $424K in Q1 2026.
  • 52 funds tracked by Wall St. Rank held BioCryst Pharmaceuticals as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.